Dare Bioscience (DARE) Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene Pivotal Study Clinical Trial Sites Nov 13, 2024 08:07AM
Dare Bioscience (DARE) Announces Grant to Support Biotherapeutic Product Development Jan 17, 2024 08:05AM
Pre-Open Stock Movers 07/07: (DARE) (OPNT) (BHVN) Higher; (BSQR) (IDYA) (LOAN) Lower (more...) Jul 7, 2021 09:26AM
Dare Bioscience (DARE) Surges on New Bill & Melinda Gates Foundation Grant Jul 7, 2021 08:24AM
Dare Bioscience (DARE) awarded a new grant of up to $48.95 million from Bill & Melinda Gates Foundation Jul 7, 2021 06:18AM


Sep 21, 2020 08:08AM Dare Bioscience (DARE) Receives $0.9 million Under the Current Grant Supplement Award for Continued Development of its User-Controlled, Long Acting Reversible Contraceptive
Jun 15, 2020 08:04AM Dare Bioscience (DARE) Announces Receipt of $1.5 Million Under Current Grant Supplement Award for Continued Development of User-Controlled Long Acting Reversible Contraceptive
Nov 11, 2019 08:07AM Dare Bioscience (DARE) Reports Acquisition of Microchips Biotech Inc.
Mar 12, 2018 08:11AM Dare Bioscience (DARE) Reports Exclusive Development, Option Agreement with Orbis Biosciences for Long-acting Injectable Contraceptive